| Application no. and date | 22826859.5 (espacenet) (Federated) (European Patent Register), 20221118 | | Patent/reg. no. and date | DK/EP 4433065, 20260311 | | Publication date | 20240925 | | Priority no. and date | US 202163281206 P, 20211119 | | EP pub. no. and date |
EP 4433065 20240925 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome
Chuo-ku
Osaka-shi, Osaka 541-0045, JP | | Applicant ref. no. | P200408EPDK/SH/HK | | Inventor | SONG, Heng,
Lexington, MA 02421, US,
SUN, Kefeng,
Lexington, MA 02421, US,
CROUTHAMEL, Matthew,
Lexington, MA 02421, US,
CHEN, Grace,
Lexington, MA 02421, US,
ZHU, Andy Z.X.,
Lexington, MA 02421, US,
MICHON, Ingrid Nicolle,
Princeton, NJ 08540, US,
BURT, Howard James,
Princeton, NJ 08540, US,
BARTER, Zoe Elizabeth,
Princeton, NJ 08540, US,
NEUHOFF, Sibylle,
Princeton, NJ 08540, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/7056 (2006.01) , A61K 45/06 (2006.01) , A61P 31/22 (2006.01) | | Title | ANVENDELSE AF MARIBAVIR TIL BEHANDLING AF CYTOMEGALOVIRUSINFEKTION OG BEHANDLINGSPLANER DERAF | | Int. application no. | US2022050341 | | Int. publication no. | WO2023091625 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
